Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Receivables (2024 - 2025)

Carlsmed (CARL) has disclosed Receivables for 2 consecutive years, with $11.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 67.93% year-over-year to $11.4 million, compared with a TTM value of $11.4 million through Dec 2025, up 67.93%, and an annual FY2025 reading of $11.4 million, up 67.93% over the prior year.
  • Receivables was $11.4 million for Q4 2025 at Carlsmed, up from $11.3 million in the prior quarter.
  • Across five years, Receivables topped out at $11.4 million in Q4 2025 and bottomed at $6.8 million in Q4 2024.